|
TIPIN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.367400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.966200E-01 |
| Normal-vs-Stage2 |
8.144800E-01 |
| Normal-vs-Stage3 |
1.744960E-01 |
| Normal-vs-Stage4 |
1.872590E-01 |
| Stage1-vs-Stage2 |
9.759800E-01 |
| Stage1-vs-Stage3 |
1.929840E-01 |
| Stage1-vs-Stage4 |
2.337200E-01 |
| Stage2-vs-Stage3 |
3.019800E-01 |
| Stage2-vs-Stage4 |
2.645200E-01 |
| Stage3-vs-Stage4 |
7.257000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.648000E-01 |
| Normal-vs-AfricanAmerican |
8.167400E-01 |
| Normal-vs-Asian |
3.499000E-01 |
| Caucasian-vs-AfricanAmerican |
2.257400E-01 |
| Caucasian-vs-Asian |
6.012600E-01 |
| AfricanAmerican-vs-Asian |
2.487000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.027600E-01 |
| Normal-vs-Female |
3.467700E-02 |
| Male-vs-Female |
1.344290E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.916350E-01 |
| Normal-vs-Extreme_Weight |
8.547200E-01 |
| Normal-vs-Obese |
4.795800E-01 |
| Normal-vs-Extreme_Obese |
9.644400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.218160E-01 |
| Normal_Weight-vs-Obese |
4.026200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.659600E-01 |
| Extreme_Weight-vs-Obese |
4.655200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.657600E-01 |
| Obese-vs-Extreme_Obese |
6.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.030400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.120000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.819800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.492600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.426600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.942400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.112210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.102600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.394000E-01 |
| Normal-VS-Type2 PRCC |
8.155200E-01 |
| Normal-VS-KIRP CIMP |
3.154000E-01 |
| Normal-VS-Unclassified PRCC |
4.744200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.199400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.896400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.946200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.984800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.928800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.665800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.925200E-01 |
| Normal-vs-N1 |
4.128100E-02 |
| Normal-vs-N2 |
3.830600E-01 |
| N0-vs-N1 |
1.665530E-02 |
| N0-vs-N2 |
3.192000E-01 |
| N1-vs-N2 |
7.401700E-02 |
|
|
